DOI QR코드

DOI QR Code

Carpinus turczaninowii extract modulates arterial inflammatory response: a potential therapeutic use for atherosclerosis

  • Son, Youn Kyoung (Biological and Genetic Resources Assessment Division, National Institute of Biological Resources) ;
  • Yoon, So Ra (Department of Food Science and Nutrition, Dong-A University) ;
  • Bang, Woo Young (Biological and Genetic Resources Assessment Division, National Institute of Biological Resources) ;
  • Bae, Chang-Hwan (Biological and Genetic Resources Assessment Division, National Institute of Biological Resources) ;
  • Yeo, Joo-Hong (Biological and Genetic Resources Assessment Division, National Institute of Biological Resources) ;
  • Yeo, Rimkyo (Department of Food Science and Nutrition, Dong-A University) ;
  • An, Juhyun (Department of Food Science and Nutrition, Dong-A University) ;
  • Song, Juhyun (Departments of Anatomy, Chonnam National University Medical School) ;
  • Kim, Oh Yoen (Department of Food Science and Nutrition, Dong-A University)
  • Received : 2018.12.16
  • Accepted : 2019.05.14
  • Published : 2019.08.01

Abstract

BACKGOURND/OBJECTIVES: Vascular inflammation is an important feature in the atherosclerotic process. Recent studies report that leaves and branches of Carpinus turczaninowii (C. turczaninowii) have antioxidant capacity and exert anti-inflammatory effects. However, no study has reported the regulatory effect of C. turczaninowii extract on the arterial inflammatory response. This study therefore investigated modulation of the arterial inflammatory response after exposure to C. turczaninowii extract, using human aortic vascular smooth muscle cells (HAoSMCs). MATERIALS/METHODS: Scavenging activity of free radicals, total phenolic content (TPC), cell viability, mRNA expressions, and secreted levels of cytokines were measured in LPS-stimulated (10 ng/mL) HAoSMCs treated with the C. turczaninowii extract. RESULTS: C. turczaninowii extract contains high amounts of TPC ($225.6{\pm}21.0mg$ of gallic acid equivalents/g of the extract), as well as exerts time-and dose-dependent increases in strongly scavenged free radicals (average $14.8{\pm}1.97{\mu}g/mL$ $IC_{50}$ at 40 min). Cell viabilities after exposure to the extracts (1 and $10{\mu}g/mL$) were similar to the viability of non-treated cells. Cytokine mRNA expressions were significantly suppressed by the extracts (1 and $10{\mu}g/mL$) at 6 hours (h) after exposure. Interleukin-6 secretion was dose-dependently suppressed 2 h after incubation with the extract, at $1-10{\mu}g/mL$ in non-stimulated cells, and at 5 and $10{\mu}g/mL$ in LPS-stimulated cells. Similar patterns were also observed at 24 h after incubation with the extract (at $1-10{\mu}g/mL$ in non-stimulated cells, and at $10{\mu}g/mL$ in the LPS-stimulated cells). Soluble intracellular vascular adhesion molecules (sICAM-1) secreted from non-stimulated cells and LPS-stimulated cells were similarly suppressed in a dose-dependent manner after 24 h exposure to the extracts, but not after 2 h. In addition, sICAM-1 concentration after 24 h treatment was positively related to IL-6 levels after 2 h and 24 h exposure (r = 0.418, P = 0.003, and r = 0.524, P < 0.001, respectively). CONCLUSIONS: This study demonstrates that C. turczaninowii modulates the arterial inflammatory response, and indicates the potential to be applied as a therapeutic use for atherosclerosis.

Keywords

References

  1. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011;12:204-12. https://doi.org/10.1038/ni.2001
  2. Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006;60:308-14. https://doi.org/10.1111/j.1368-5031.2006.00825.x
  3. Ohnuki Y, Nagano R, Takizawa S, Takagi S, Miyata T. Advanced glycation end products in patients with cerebral infarction. Intern Med 2009;48:587-91. https://doi.org/10.2169/internalmedicine.48.1390
  4. Lonn ME, Dennis JM, Stocker R. Actions of "antioxidants" in the protection against atherosclerosis. Free Radic Biol Med 2012;53:863-84. https://doi.org/10.1016/j.freeradbiomed.2012.05.027
  5. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003;52:2795-804. https://doi.org/10.2337/diabetes.52.11.2795
  6. Chae JS, Kim OY, Paik JK, Kang R, Seo WJ, Jeong TS, Sweeney G, Lee SH, Lee JH. Association of Lp-PLA(2) activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome. Atherosclerosis 2011;218:499-506. https://doi.org/10.1016/j.atherosclerosis.2011.06.036
  7. Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012;33:829-37. https://doi.org/10.1093/eurheartj/ehr304
  8. Halford JC. Obesity drugs in clinical development. Curr Opin Investig Drugs 2006;7:312-8.
  9. Marazza JA, Nazareno MA, de Giori GS, Garro MS. Enhancement of the antioxidant capacity of soymilk by fermentation with Lactobacillus rhamnosus. J Funct Foods 2012;4:594-601. https://doi.org/10.1016/j.jff.2012.03.005
  10. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11. https://doi.org/10.1016/0140-6736(93)92876-U
  11. Chen Y, Wang J, Ou Y, Chen H, Xiao S, Liu G, Cao Y, Huang Q. Cellular antioxidant activities of polyphenols isolated from Eucalyptus leaves (Eucalyptus grandis $\times$ Eucalyptus urophylla GL9). J Funct Foods 2014;7:737-45. https://doi.org/10.1016/j.jff.2013.12.003
  12. Zheng G, Xu L, Wu P, Xie H, Jiang Y, Chen F, Wei X. Polyphenols from longan seeds and their radical-scavenging activity. Food Chem 2009;116:433-6. https://doi.org/10.1016/j.foodchem.2009.02.059
  13. Jin T, Kim OY, Shin MJ, Choi EY, Lee SS, Han YS, Chung JH. Fisetin up-regulates the expression of adiponectin in 3T3-L1 adipocytes via the activation of silent mating type information regulation 2 homologue 1 (SIRT1)-deacetylase and peroxisome proliferator-activated receptors (PPARs). J Agric Food Chem 2014;62:10468-74. https://doi.org/10.1021/jf502849j
  14. Moon J, Do HJ, Kim OY, Shin MJ. Antiobesity effects of quercetinrich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food Chem Toxicol 2013;58:347-54. https://doi.org/10.1016/j.fct.2013.05.006
  15. Ko HN, Oh TH, Baik JS, Hyun CG, Kim SS, Lee NH. Anti-inflammatory activities for the extracts and Carpinontriols from branches of Caripinus Turczaninowii. Int J Pharmacol 2013;9:157-63. https://doi.org/10.3923/ijp.2013.157.163
  16. Ko HN, Kim JM, Bu HJ, Lee NH. Chemical constituents from the branches of Carpinus turczaninowii with antioxidative activities. J Korean Chem Soc 2013;57:520-4. https://doi.org/10.5012/jkcs.2013.57.4.520
  17. Kang JM. Identification of anti-oxidative, skin whitening, antiinflammatory and anti-bacterial constituents from the leaves of Carpinus turczaninowii Hance [master's thesis]. Jeju: Jeju National University; 2015.
  18. Jeon JI, Chang CS. Foliar flavonoids of genus Carpinus in eastern Asia primarily based on native taxa to Korea. Korean J Plant Taxon 2000;30:139-53. https://doi.org/10.11110/kjpt.2000.30.2.139
  19. Chang CS, Chang KS. Typification of Corylopsis coreana (Hamamelidaceae) and Carpinus laxiflora var. longispica (Betulaceae). Shokubutsu Kenkyu Zasshi 2010;85:270-6.
  20. Brand-Williams W, Cuvelier ME, Berset C. Use of free radical method to evaluate antioxidant activity. Lebenson Wiss Technol 1995;28:25-30. https://doi.org/10.1016/S0023-6438(95)80008-5
  21. Deshpande SS, Cheryan M. Determination of phenolic compounds of dry beans using vanillin, redox and precipitation assays. J Food Sci 1987;52:332-4. https://doi.org/10.1111/j.1365-2621.1987.tb06606.x
  22. Yang EJ, Yim EY, Song G, Kim GO, Hyun CG. Inhibition of nitric oxide production in lipopolysaccharide-activated RAW 264.7 macrophages by Jeju plant extracts. Interdiscip Toxicol 2009;2:245-9. https://doi.org/10.2478/v10102-009-0022-2
  23. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 1999;100:1148-50. https://doi.org/10.1161/01.CIR.100.11.1148
  24. Schildberger A, Rossmanith E, Eichhorn T, Strassl K, Weber V. Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm 2013;2013:697972.
  25. Brasier AR. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 2010;86:211-8. https://doi.org/10.1093/cvr/cvq076
  26. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-93.
  27. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 1995;60:9-15. https://doi.org/10.1016/0165-5728(95)00047-6
  28. Vejlsgaard GL, Ralfkiaer E, Avnstorp C, Czajkowski M, Marlin SD, Rothlein R. Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas. J Am Acad Dermatol 1989;20:782-90. https://doi.org/10.1016/S0190-9622(89)70090-6
  29. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989;83:2008-17. https://doi.org/10.1172/JCI114111
  30. Shijubo N, Imai K, Shigehara K, Honda Y, Koba H, Tsujisaki M, Hinoda Y, Yachi A, Ohmichi M, Hiraga Y, Abe S. Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Clin Exp Immunol 1994;95:156-61. https://doi.org/10.1111/j.1365-2249.1994.tb06030.x
  31. Tsukada N, Matsuda M, Miyagi K, Yanagisawa N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology 1993;43:2679-82. https://doi.org/10.1212/WNL.43.12.2679
  32. Teppo AM, von Willebrand E, Honkanen E, Ahonen J, Gronhagen-Riska C. Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1? Transplantation 2001;71:1113-9. https://doi.org/10.1097/00007890-200104270-00018
  33. Bongard V, Elias A, Bal dit Sollier C, Ruidavets J, Boccalon H, Drouet L, Ferrieres J. Soluble intercellular adhesion molecule-1 is associated with carotid and femoral atherosclerosis but not with intima-media thickness in a population-based sample. Atherosclerosis 2002;164:297-304. https://doi.org/10.1016/S0021-9150(02)00071-0
  34. Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997;85:433-8. https://doi.org/10.1016/S0049-3848(97)00031-5
  35. Rohde LE, Hennekens CH, Ridker PM. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 1999;19:1595-9. https://doi.org/10.1161/01.ATV.19.7.1595
  36. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr, Ballantyne CM. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996;93:1334-8. https://doi.org/10.1161/01.CIR.93.7.1334
  37. Abe Y, El-Masri B, Kimball KT, Pownall H, Reilly CF, Osmundsen K, Smith CW, Ballantyne CM. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 1998;18:723-31. https://doi.org/10.1161/01.ATV.18.5.723
  38. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92. https://doi.org/10.1016/S0140-6736(97)09032-6
  39. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26. https://doi.org/10.1056/NEJM199901143400207
  40. Marino M, Scuderi F, Mazzarelli P, Mannella F, Provenzano C, Bartoccioni E. Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts. J Neuroimmunol 2001;116:94-101. https://doi.org/10.1016/S0165-5728(01)00287-9
  41. Ghaisas NK, Shahi CN, Foley B, Goggins M, Crean P, Kelly A, Kelleher D, Walsh M. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol 1997;80:617-9. https://doi.org/10.1016/S0002-9149(97)00432-3
  42. Frohman EM, Frohman TC, Dustin ML, Vayuvegula B, Choi B, Gupta A, van den Noort S, Gupta S. The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J Neuroimmunol 1989;23:117-24. https://doi.org/10.1016/0165-5728(89)90030-1
  43. Thomson AW, Satoh S, Nussler AK, Tamura K, Woo J, Gavaler J, van Thiel DH. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol 1994;95:83-90. https://doi.org/10.1111/j.1365-2249.1994.tb06019.x
  44. Chen NG, Azhar S, Abbasi F, Carantoni M, Reaven GM. The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers. Atherosclerosis 2000;152:203-8. https://doi.org/10.1016/S0021-9150(99)00460-8
  45. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 2000;85:2572-5. https://doi.org/10.1210/jcem.85.7.6677